Monika Maria Toernsen - 15 Sep 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Commercial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
15 Sep 2022
Net transactions value
-$2,539
Form type
4
Filing time
18 Nov 2022, 16:01:06 UTC
Previous filing
11 Jul 2022
Next filing
29 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PASG Common Stock Options Exercise +5,000 5,000 15 Sep 2022 Direct F1
transaction PASG Common Stock Sale $2,539 -1,681 -34% $1.51 3,319 19 Sep 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Restricted Stock Unit Options Exercise $0 -5,000 -25% $0.000000 15,000 15 Sep 2022 Common Stock 5,000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F3 Each RSU represents a contingent right to receive one share of Issuer's common stock.
F4 1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.